Okklo Life Sciences2018-09-26T19:22:06+00:00

Okklo Life Sciences

Okklo Life Sciences is a privately held biopharmaceutical company developing novel therapeutic solutions using cyclodextrin-based technologies, with a focus on neglected and orphan diseases.
The company was founded in December 2011 by a team of life-sciences experts previously involved in the development and approval of sugammadex (Bridion™), the first modified cyclodextrin (CD) marketed as a drug product.

Voor meer informatie klik hier.

Kadans Community

Weten of Kadans, of iemand in de Kadans Community, zoals een van de Kadans huurders of partners u kan helpen of inspireren? Wij verbinden graag!

CONTACT